Ultrasound-guided Thoracic Paravertebral Block for the Treatment of Acute Herpes Zoster

Ultrasound-guided Thoracic Paravertebral Block for the Treatment of Acute Herpes Zoster:A Randomized-controlled Clinical Study with Two Different Approaches

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044335

Enrollment

Unknown

Registered

2021-03-14

Start date

2021-04-01

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Control Group:Standard antiviral

Trial Group 1:standard antiviral +TPVB under US-guided using TSA approach

Trial Group 2:standard antiviral +TPVB using POS approach

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as HZ in the thoracic dermatomal; 2. Presented to our pain clinic within 2 weeks from the initial onset of HZ rash; 3. Aged 50 years or older; 4. HZ-associated pain defined as a score of > 3 in the average pain question of the Zoster Brief Pain Inventory (ZBPI); 5. Complete the whole TPVB injection therapy; 6. Follow-up using the routine guideline; 7. Complete medical record data.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had immunity dysfunction, hepatic or renal dysfunction, coagulation disorders, systemic use of antivirals and pregnancy/lactation.

Design outcomes

Primary

Measure	Time frame
illness burden associated to herpes zoster;	—

Countries

China

Contacts

Public ContactLi Niu

Heilongjiang Red Cross Sengong General Hospital

niuli0306@163.com+86 15211090075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026